Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05822635 · ClinicalTrials.gov registry record
SpyGlass Surgical Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 34
- Enrollment target
NCT05822635 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 34 participants.
The verdict
NCT05822635 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
* To document the clinical utility of diagnostic and/or therapeutic intraoperative endoscopy using a thin, single-use, flexible cholangiopancreatoscope * To identify specific surgical procedures in which intraoperative use of a thin, single use, flexible cholangiopancreatoscope suggests clinically meaningful benefit and generate a hypothesis for possible subsequent claims-supportive study
Interventions
- DEVICE SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2025-01-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05822635
The ClinicalTrials.gov registry entry for NCT05822635 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System is the first listed.
NCT05822635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05822635 about?
NCT05822635 is a clinical study titled "SpyGlass Surgical Study". * To document the clinical utility of diagnostic and/or therapeutic intraoperative endoscopy using a thin, single-use, flexible cholangiopancreatoscope * To identify specific surgical procedures in which intraoperative use of a thin, single use, flexible cholangiopancreatoscope suggests clinically m...
What is the current status of trial NCT05822635?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2023-12-01. Estimated completion is 2025-01-03.
What interventions are being tested in trial NCT05822635?
The interventions under investigation include: SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System (DEVICE).
Who is sponsoring clinical trial NCT05822635?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.